当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2016年第2期
编号:12758545
稳定过表达microRNA—96前列腺癌细胞株的建立及其对前列腺癌细胞增殖和迁移的影响(5)
http://www.100md.com 2016年1月15日 中国医药导报 2016年第2期
     [16] Deng D,Liu Z,Du Y. Epigenetic alterations as cancer diagnostic,prognostic,and predictive biomarkers [J]. Adv Genet,2010,71:125-176.

    [17] Gernone A,Bordonaro S,Tralongo P. Optimal sequence of bone target drugs in metastatic prostatic cancer [J]. Expert Rev Anticancer Ther,2015,15(8):923-929.

    [18] Nicolaidou V,Koufaris C. MicroRNA responses to environmental liver carcinogens:biological and clinical significance [J]. Clin Chim Acta,2015,445:25-33.

    [19] Kiriakidou M,Tan GS,Lamprinaki S,et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation [J]. Cell,2007,129(6):1141-1151.

    [20] Zeng Y. Principles of micro-RNA production and maturation [J]. Oncogene,2006,25(46):6156-6162.

    [21] Shomron N,Levy C. MicroRNA-biogenesis and pre-mRNA splicing crosstalk [J]. J Biomed Biotechnol,2009,2009:594678.

    [22] Jemal A,Siegel R,Ward E,et al. Cancer statistics,2008 [J]. CA Cancer J Clin,2008,58(2):71-96.

    [23] Kriebel S,Schmidt D,Holdenrieder S,et al. Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer [J]. PLoS One,2015, 10(1):e117284.

    [24] Siu MK,Tsai YC,Chang YS,et al. Transforming growth factor-beta promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway [J]. Oncogene,2015,(34):4767-4776.

    (收稿日期:2015-06-15 本文编辑:李亚聪), 百拇医药(李勇波 张孝斌 程帆 饶婷 余伟民)
上一页1 2 3 4 5